Rikard Holmdahl

Professor Rikard Holmdahl holds a medical degree and a Ph.D. in immunology from Uppsala University, Sweden, and has held several senior scientific positions within academia. In 1990 he was appointed Associate Professor at the Swedish Medical Research Council, and in 1993 he set up the Medical Inflammation Research group at Lund University as a full Professor at the university. Since 2008 he holds the position of Professor at the Karolinska Institutet (KI) in Stockholm, and since 2014 he is a member of the Nobel Assembly. In addition to his position at KI, he is also a scientific advisor and consultant for biotech and biomedical companies. Rikard Holmdahl actively performs research in the areas of RA and MS and has formerly been intimately involved in the understanding of Rabeximod mechanism of action.